BioNexus Gene Lab Corp. (BGLC)

USD 0.26

(-2.99%)

Net Income Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual net income in 2023 was -2.62 Million USD , down -638.57% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly net income in 2024 Q2 was 199.1 Thousand USD , up 291.89% from previous quarter.
  • BioNexus Gene Lab Corp. reported an annual net income of -355.96 Thousand USD in 2022, down -147.36% from previous year.
  • BioNexus Gene Lab Corp. reported an annual net income of 751.57 Thousand USD in 2021, down -31.31% from previous year.
  • BioNexus Gene Lab Corp. reported a quarterly net income of -103.75 Thousand USD for 2024 Q1, down -133.75% from previous quarter.
  • BioNexus Gene Lab Corp. reported a quarterly net income of -2.6 Million USD for 2023 Q3, down -906.03% from previous quarter.

Annual Net Income Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Net Income of BioNexus Gene Lab Corp. (2023 - 2016)

Year Net Income Net Income Growth
2023 -2.62 Million USD -638.57%
2022 -355.96 Thousand USD -147.36%
2021 751.57 Thousand USD -31.31%
2020 1.09 Million USD 543.91%
2019 -246.46 Thousand USD -1031.69%
2018 26.45 Thousand USD 121.38%
2017 -123.75 Thousand USD -14720.36%
2016 -835.00 USD 0.0%

Peer Net Income Comparison of BioNexus Gene Lab Corp.

Name Net Income Net Income Difference
Bionano Genomics, Inc. -232.49 Million USD 98.869%
Prenetics Global Limited -62.72 Million USD 95.809%
Star Equity Holdings, Inc. -1.54 Million USD -69.835%
CareDx, Inc -190.28 Million USD 98.618%
Exact Sciences Corporation -204.14 Million USD 98.712%
Exagen Inc. -23.68 Million USD 88.902%
Inotiv, Inc. -105.14 Million USD 97.499%
Guardant Health, Inc. -479.44 Million USD 99.452%
Biodesix, Inc. -52.14 Million USD 94.958%
Precipio, Inc. -5.85 Million USD 55.082%
iSpecimen Inc. -11.09 Million USD 76.314%
Natera, Inc. -434.8 Million USD 99.395%
Aspira Women's Health Inc. -16.69 Million USD 84.248%
Standard BioTools Inc. -74.65 Million USD 96.478%
23andMe Holding Co. -666.7 Million USD 99.606%
Castle Biosciences, Inc. -57.46 Million USD 95.425%
Personalis, Inc. -108.29 Million USD 97.572%
Aclaris Therapeutics, Inc. -88.48 Million USD 97.029%
Applied DNA Sciences, Inc. -9.94 Million USD 73.57%
OpGen, Inc. -32.66 Million USD 91.952%
T2 Biosystems, Inc. -50.07 Million USD 94.75%
Myriad Genetics, Inc. -112 Million USD 97.653%
ICON Public Limited Company 612.33 Million USD 100.429%
NeoGenomics, Inc. -87.96 Million USD 97.011%
Star Equity Holdings, Inc. -1.54 Million USD -69.835%
IDEXX Laboratories, Inc. 845.04 Million USD 100.311%
RadNet, Inc. 3.04 Million USD 186.368%
MDxHealth SA -43.1 Million USD 93.9%
Psychemedics Corporation -4.15 Million USD 36.711%
Illumina, Inc. -1.16 Billion USD 99.774%
Check-Cap Ltd. -17.56 Million USD 85.035%
Twist Bioscience Corporation -208.72 Million USD 98.74%
DarioHealth Corp. -59.42 Million USD 95.576%
Fulgent Genetics, Inc. -167.82 Million USD 98.433%
Sera Prognostics, Inc. -36.24 Million USD 92.746%
ENDRA Life Sciences Inc. -10.06 Million USD 73.867%
OPKO Health, Inc. -188.86 Million USD 98.608%
Medpace Holdings, Inc. 282.81 Million USD 100.93%
Neogen Corporation -9.42 Million USD 72.094%
Intelligent Bio Solutions Inc. -10.15 Million USD 74.115%
Prenetics Global Limited -62.72 Million USD 95.809%
Mainz Biomed B.V. -26.29 Million USD 90.002%
bioAffinity Technologies, Inc. -7.93 Million USD 66.876%
Trinity Biotech plc -24.01 Million USD 89.054%
Neuronetics, Inc. -30.18 Million USD 91.291%
Sotera Health Company 51.37 Million USD 105.117%
bioAffinity Technologies, Inc. -7.93 Million USD 66.876%